AnalystsNeil ChatterjiNeil Chatterji's Stock Forecasts
AnalystsNeil Chatterji
Analyst Ranking
Bottom 8%
#4235 out of 4559 analysts
Average Return
-17.65%
Win Rate
25%4 out of 16
Risk vs Reward
Poor
Good
Neil Chatterji's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Establishment Labs Holdings IncESTA | +111.90% | $22.78 | $48.27 | 2023-11-09 - 2024-04-22 | Strong Buy |
Hyperfine IncHYPR | +85.44% | $1.03 | $1.91 | 2022-10-04 - 2023-10-03 | Strong Buy |
Stereotaxis IncSTXS | +4.74% | $2.32 | $2.43 | 2023-03-06 - 2024-03-05 | Strong Buy |
Optimizerx CorpOPRX | +0.11% | $9.08 | $9.09 | 2023-08-15 - 2024-04-22 | Strong Buy |
Neil Chatterji Analyst Color
Get additional color on Neil Chatterji's coverage of popular stocks
Neil Chatterji's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
AUGX | 3 | Strong Buy | $5.50 | +310.45% | Reinstates | 20 days ago |
Establishment Labs Holdings IncESTA | 2 | Strong Buy | $50.00 | +3.58% | Maintains | 5 months ago |
Silk Road Medical IncSILK | 3 | Hold | $14.00 | -19.59% | Downgrades | 6 months ago |
Accuray IncARAY | 1 | Strong Buy | $7.50 | +245.62% | Reiterates | 7 months ago |
Zumiez IncZUMZ | 2 | Hold | $18.00 | +13.42% | Maintains | 7 months ago |
Koru Medical Systems IncKRMD | 1 | Strong Buy | $4.50 | +111.27% | Initiates Coverage On | 8 months ago |
Optimizerx CorpOPRX | 2 | Strong Buy | $18.00 | +98.02% | Maintains | 8 months ago |
Hyperfine IncHYPR | 3 | Strong Buy | $3.50 | +311.76% | Maintains | 8 months ago |
Stereotaxis IncSTXS | 2 | Strong Buy | $5.50 | N/A | Maintains | a year ago |
Clearpoint Neuro IncCLPT | 1 | Strong Buy | $14.00 | N/A | Reinstates | a year ago |
Paragon 28 IncFNA | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | a year ago |
Butterfly Network IncBFLY | 1 | Strong Buy | $9.50 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.